Benedikt E.
- Country
- Belgium
- Department
- Radiotherapy-Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 14 partner sites.
Specializations
Prostate Cancer Treatment
This clinical investigator specializes in the treatment of oligorecurrent hormone-sensitive prostate cancer, with particular focus on developing innovative therapeutic approaches for patients experiencing disease recurrence after initial treatment.
- Metastasis-Directed Therapy (MDT)
- Hormone Therapy Management
- Limited Metastatic Disease
The investigator explores therapeutic strategies for patients with up to five metastases, integrating various treatment modalities.
Therapeutic Innovation
The investigator's work centers on combining androgen receptor targeted therapy with other treatment approaches to enhance patient outcomes. Their research examines the effectiveness of different treatment durations and combinations.
- Short-term Androgen Deprivation Therapy
- Combined Treatment Approaches
- Treatment Duration Optimization
Key areas include the assessment of treatment responses and the management of hormone-sensitive disease states.
Disease Monitoring
The investigator focuses on tracking castration-resistant prostate cancer progression and developing methods to monitor treatment effectiveness through biochemical markers.
- PSA Progression Monitoring
- Biochemical Recurrence Assessment
- Treatment Response Evaluation
Their work includes the development of precise criteria for measuring disease progression and treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.